39919-65-8
39919-65-8
Chemical Structure
3,6-Dibromo-2-methylpyridine
- CAS No.: 39919-65-8
- Formula:C6H5Br2N
- Molecular Weight:250.92
IUPAC Name: 3,6-dibromo-2-methylpyridine
InChIKey: UCHKRHGVKYVGTC-UHFFFAOYSA-N
SMILES: CC1=C(Br)C=CC(Br)=N1
Biological Activity: 3,6-Dibromo-2-methylpyridine is a key intermediate in organic synthesis. 3,6-Dibromo-2-methylpyridine can be used in the study of pulmonary fibrosis and PRC2-dependent cancers[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3,6-Dibromo-2-methylpyridine | 99.58% | 3,6-Dibromo-2-methylpyridine is a key intermediate in organic synthesis. 3,6-Dibromo-2-methylpyridine can be used in the study of pulmonary fibrosis and PRC2-dependent cancers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Cheng PTW, et al. Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases. J Med Chem. 2021 Nov 11;64(21):15549-15581. [Content Brief]
- [2]. Hsu JH, et al. EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex. Cell Chem Biol. 2020 Jan 16;27(1):41-46.e17. [Content Brief]
